Kolon Life (Korea) Performance
| 102940 Stock | KRW 22,300 50.00 0.22% |
On a scale of 0 to 100, Kolon Life holds a performance score of 7. The company secures a Beta (Market Risk) of 1.58, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kolon Life will likely underperform. Please check Kolon Life's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Kolon Life's current price movements will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Kolon Life Science are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kolon Life sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -2.3 B |
Kolon |
Kolon Life Relative Risk vs. Return Landscape
If you would invest 1,887,000 in Kolon Life Science on November 8, 2024 and sell it today you would earn a total of 343,000 from holding Kolon Life Science or generate 18.18% return on investment over 90 days. Kolon Life Science is generating 0.3626% of daily returns and assumes 3.8952% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Kolon, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Kolon Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kolon Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kolon Life Science, and traders can use it to determine the average amount a Kolon Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0931
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 102940 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Kolon Life is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kolon Life by adding it to a well-diversified portfolio.
Kolon Life Fundamentals Growth
Kolon Stock prices reflect investors' perceptions of the future prospects and financial health of Kolon Life, and Kolon Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kolon Stock performance.
| Return On Equity | -6.82 | |||
| Return On Asset | -0.0218 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 437.45 B | |||
| Shares Outstanding | 11.41 M | |||
| Price To Earning | 286.10 X | |||
| Price To Sales | 3.32 X | |||
| Revenue | 165.49 B | |||
| EBITDA | (7.05 B) | |||
| Cash And Equivalents | 27.8 B | |||
| Total Debt | 4.19 B | |||
| Debt To Equity | 16.60 % | |||
| Cash Flow From Operations | (16.19 B) | |||
| Total Asset | 234.66 B | |||
| Retained Earnings | 77.45 B | |||
| Current Asset | 83.96 B | |||
| Current Liabilities | 42.04 B | |||
About Kolon Life Performance
By analyzing Kolon Life's fundamental ratios, stakeholders can gain valuable insights into Kolon Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kolon Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kolon Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, antimicrobials, and water solutions primarily in South Korea. Kolon Life Science Inc. was founded in 2000 and is headquartered in Gwacheon, South Korea. Kolon Life is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Kolon Life Science performance evaluation
Checking the ongoing alerts about Kolon Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kolon Life Science help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kolon Life Science had very high historical volatility over the last 90 days | |
| The company reported the revenue of 165.49 B. Net Loss for the year was (1.37 B) with profit before overhead, payroll, taxes, and interest of 18.74 B. | |
| Kolon Life Science has accumulated about 27.8 B in cash with (16.19 B) of positive cash flow from operations. | |
| Roughly 36.0% of the company shares are owned by insiders or employees |
- Analyzing Kolon Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kolon Life's stock is overvalued or undervalued compared to its peers.
- Examining Kolon Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kolon Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kolon Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kolon Life's stock. These opinions can provide insight into Kolon Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kolon Stock analysis
When running Kolon Life's price analysis, check to measure Kolon Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kolon Life is operating at the current time. Most of Kolon Life's value examination focuses on studying past and present price action to predict the probability of Kolon Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kolon Life's price. Additionally, you may evaluate how the addition of Kolon Life to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |